Boosting a Natural Brain Cannabinoid Enhanced Fear Memory Through CB2 Receptors in Rats
Inhibiting the breakdown of the endocannabinoid 2-AG strengthened fear memory consolidation in rats through CB2 receptor activation and suppression of mTOR signaling in the hippocampus.
Quick Facts
What This Study Found
The MAGL inhibitor JZL184, which boosts 2-AG levels, enhanced memory consolidation when given right after training in a fear-based learning task. This effect was mediated specifically through CB2 receptors and involved suppression of the mTOR signaling pathway in the hippocampus.
Key Numbers
JZL184 enhanced memory consolidation. CB2 antagonist AM630 blocked the effect, while CB1 antagonist AM251 did not. 2-AG signaling prevented mTOR activation in the hippocampus via CB2.
How They Did This
Rats were trained on an inhibitory avoidance task (a fear-based learning paradigm). JZL184 was administered immediately after training. CB1 and CB2 antagonists were used to determine which receptor mediated the memory effect. mTOR pathway components were measured in hippocampal tissue.
Why This Research Matters
Most endocannabinoid research on memory has focused on CB1 receptors. This study reveals that 2-AG and CB2 receptors play a fundamental role in how the brain consolidates memories of aversive experiences, opening a new research direction.
The Bigger Picture
Understanding how the endocannabinoid system modulates memory for stressful events has implications for conditions like PTSD, where traumatic memories are abnormally persistent. CB2-targeted therapies could potentially modulate this process without the psychoactive effects associated with CB1.
What This Study Doesn't Tell Us
Animal study with acute drug administration. The inhibitory avoidance task measures a specific type of memory. Results may not generalize to other memory types or to humans.
Questions This Raises
- ?Could CB2-targeted drugs help regulate traumatic memory formation in humans?
- ?Does this 2-AG/CB2 pathway contribute to the memory effects reported by cannabis users?
- ?How does this interact with the previously identified anandamide/CB1 pathway?
Trust & Context
- Key Stat:
- Memory enhancement was blocked by a CB2 antagonist but not a CB1 antagonist, pinpointing CB2 as the key receptor for 2-AG's memory effects.
- Evidence Grade:
- Preliminary - single animal study, though mechanistically detailed with multiple validation approaches.
- Study Age:
- Published in 2018.
- Original Title:
- Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.
- Published In:
- Neuropharmacology, 138, 210-218 (2018)
- Authors:
- Ratano, Patrizia, Petrella, Carla, Forti, Fabrizio, Passeri, Pamela Petrocchi, Morena, Maria, Palmery, Maura, Trezza, Viviana, Severini, Cinzia, Campolongo, Patrizia
- Database ID:
- RTHC-01805
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
How does the endocannabinoid system affect memory?
This study showed that the endocannabinoid 2-AG strengthens memory consolidation for aversive experiences through CB2 receptors. Previous work found anandamide does something similar through CB1 receptors, suggesting both major endocannabinoids regulate emotional memory.
What is 2-AG?
2-arachidonoylglycerol (2-AG) is one of the two major endocannabinoids - molecules the brain naturally produces that act on the same receptors as THC. It is the most abundant endocannabinoid in the brain.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-01805APA
Ratano, Patrizia; Petrella, Carla; Forti, Fabrizio; Passeri, Pamela Petrocchi; Morena, Maria; Palmery, Maura; Trezza, Viviana; Severini, Cinzia; Campolongo, Patrizia. (2018). Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.. Neuropharmacology, 138, 210-218. https://doi.org/10.1016/j.neuropharm.2018.05.030
MLA
Ratano, Patrizia, et al. "Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.." Neuropharmacology, 2018. https://doi.org/10.1016/j.neuropharm.2018.05.030
RethinkTHC
RethinkTHC Research Database. "Pharmacological inhibition of 2-arachidonoilglycerol hydroly..." RTHC-01805. Retrieved from https://rethinkthc.com/research/ratano-2018-pharmacological-inhibition-of-2arachidonoilglycerol
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.